AMERSA

AMERSA

Call Us: (401) 615-4047 | Contact Us AMERSA on Twitter AMERSA on LinkedIn AMERSA on BlueSky

Make a Donation Pay a Past-Due Balance Join Our Mailing List
  • About
    • What is AMERSA
    • Board of Directors
    • Donate to AMERSA
    • Contact Us
  • Membership
    • Get to Know AMERSA
    • Join / Renew
    • Who We Are
    • Member Center
    • Special Interest Groups
    • Career Opportunities
    • Professional & Academic Advancement Opps
  • Conference
    • Annual Conference
    • Conference Sponsorship
    • Conference Exhibitor Information
    • Policy and Procedures for AMERSA Events
    • 2024 Conference Materials
    • Past Conference Resources
  • Journal
    • Journal Home
    • About Us
    • Member Access to Journal
    • Author Instructions and Submission
    • SAj Blog
    • SAj Annual Awards
    • SAj Editorial Scholar Program
  • Advocacy
    • AMERSA Advocacy
    • Position Statements
    • Submit a Position Statement
    • Letters of Support
    • Public Comments
  • Sustainability
    • Initiatives
    • Resources
  • Education
    • AMERSA Podcast Series
    • AMERSA Webinars
    • Core Competencies – AMERSA in the 21st Century
    • Resources
  • Awards
    • AMERSA Awards
    • Current Award Winners
    • Past Award Winners

The Authors’ Own Words: Characteristics of methadone maintenance treatment patients prescribed opioid analgesics

Aug 18, 2016 by AMERSA

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Characteristics of methadone maintenance treatment patients prescribed opioid analgesics
Matthew C. Glenn, Nancy L. Sohler, Joanna L. Starrels, Jeronimo Maradiaga, John J. Jost, Julia H. Arnsten, and Chinazo O. Cunningham
Substance Abuse Vol. 37 , Iss. 3,2016

Despite the potential iatrogenic hazards of concurrent methadone treatment and opioid analgesic prescription, the published literature has focused on illicit opioid use amongst MMT patients. Our novel findings suggest high prevalence of prescription opioid overuse amongst opioid analgesic-prescribed MMT patients, higher prevalence of HIV infection and chronic pain when compared to MMT patients not prescribed opioid analgesics, and similarly high rates of illicit substance use across all MMT patients, regardless of opioid analgesic prescription. Thus, the opioid analgesic-prescribed MMT population represents a very high risk group due to the potential for overdose. These findings highlight the complex challenges facing physicians treating patients with comorbid chronic pain and opioid dependence and adds to the body of literature calling for coordinated and integrated strategies to treating these patients.

————————————————————————————————-
Our newly released issue is now online —> July-September 2016.
————————————————————————————————-

Filed Under: SAj Blog, The Authors' Own Words

Copyright © 2025
Site by: web360